Latest stories on TNDM
Tandem Diabetes price target lowered to $18 from $20 at Mizuho
The Fly34 · bearishanalyst
Tandem Diabetes initiated with an Equal Weight at Barclays
The Fly50 · neutralanalyst
Solar producers near commercialization of tandem solar panels, NYT reports
The Fly63 · neutralproduct/pr
Tandem Diabetes Care to Announce Third Quarter 2026 Financial Results on November 5, 2026
StockTitan50 · neutralearnings
Citi cuts Tandem target, opens ‘upside 90-day catalyst watch’
The Fly48 · neutralanalyst
Tandem Diabetes says Tandem Mobi now available in 12 international markets
The Fly63 · neutralproduct/pr
Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets
StockTitan63 · neutralproduct/pr
Why is Tandem stock surging today?
Investing.com Markets50 · neutralgeneral
25% of Financial Institutions Report Suspected or Confirmed Deepfake Incidents, New Survey Finds
PR Newswire38 · neutralgeneral
Tandem Diabetes Care: Stop Paying For Tomorrow's Profits - Strong Sell
Seeking Alpha22 · bearishanalyst
Tandem Diabetes initiated with an Outperform at William Blair
The Fly61 · neutralanalyst
Tandem Diabetes (TNDM) Q2 2026 Earnings Call Transcript
The Motley Fool68 · bullishearnings
Powerus, Aureus Greenway Holdings Inc. announce $2.51M purchase order for drones in support of Department of War program
Business Insider63 · neutralgeneral
Powerus, Aureus Greenway Holdings Inc. announce $2.51M purchase order for drones in support of Department of War program
GlobeNewswire63 · neutralgeneral
Tandem Diabetes Care, Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Tandem forecasts $265M Q3 sales while advancing Mobi tubeless scaled launch in H2 2026
Seeking Alpha63 · neutralproduct/pr
Tandem Diabetes Care, Inc. (TNDM) Q2 2026 Earnings Call Transcript
Seeking Alpha56 · neutralearnings
Tandem Diabetes Price Target Lowered To 26 From 30 At Rbc Capital
The Fly34 · bearishanalyst
Tandem Diabetes price target raised to $40 from $35 at Canaccord
The Fly61 · neutralanalyst
Tandem Diabetes price target raised to $21 from $17 at Citi
The Fly61 · neutralanalyst
Oppenheimer reiterates Tandem Diabetes stock rating on pharmacy gains
Investing.com Analyst Ratings56 · neutralanalyst
Tandem Diabetes sees FY26 revenue $1.065B-$1.085B, consensus $1.08B
The Fly58 · neutralearnings
Tandem Diabetes Reports Q2 Eps 31c Consensus 32c
The Fly48 · neutralearnings
Tandem Diabetes Care GAAP EPS of -$0.31 beats by $0.01, revenue of $254.6M misses by $0.47M
Seeking Alpha56 · neutralearnings